NCT01155375View on ClinicalTrials.gov

A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease

PHASE3TerminatedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 17, 2011

Primary Completion Date

June 24, 2014

Study Completion Date

June 24, 2014

Conditions
Iron Deficiency Anemia
Interventions
DRUG

Ferumoxytol

Experimental: Ferumoxytol

DRUG

Oral Iron

Active Comparator: Oral iron

Trial Locations (1)

02451

AMAG Pharmaceuticals, Inc., Waltham

Sponsors
All Listed Sponsors
lead

AMAG Pharmaceuticals, Inc.

INDUSTRY